Hypertension, Vol 11, 411-415, Copyright © 1988 by American Heart Association
M Nakagawa and A Nasjletti
We investigated the status of circulating kinins in rats with severe
hypertension caused by drinking 1% NaCl (saline) and treatment with
deoxycorticosterone (DOC, 25 mg/kg/wk s.c.) for 5 weeks. Saline- drinking
rats treated with DOC had a higher systolic blood pressure (210 +/- 4 mm
Hg) than did rats without DOC treatment drinking water (138 +/- 3 mm Hg) or
saline (141 +/- 3 mm Hg). The concentration of kinins in the inferior vena
cava plasma of DOC-salt hypertensive rats did not differ from the venous
plasma kinin concentration in normotensive rats drinking water or saline.
In contrast, the arterial plasma kinin concentration in DOC-salt
hypertensive rats (7.0 +/- 0.8 pg/ml) was lower (p less than 0.002) than
that in water-drinking controls (14.0 +/- 2.2 pg/ml); it also was lower (p
less than 0.005) in saline-drinking rats (8.1 +/- 0.9 pg/ml) than in
water-drinking controls. Infusion of bradykinin (20 micrograms/kg/min i.v.)
increased arterial plasma kinins in all the groups. Nonetheless, the
arterial plasma kinin concentration achieved during bradykinin infusion in
DOC- salt hypertensive (1590 +/- 130 pg/ml) and in saline-drinking rats
(1540 +/- 100 pg/ml) was lower than that in water-drinking rats (2140 +/-
210 pg/ml). On the other hand, during infusion of the kininase II inhibitor
captopril (80 micrograms/hr i.p.) for 3 days, neither DOC- salt
hypertensive rats nor saline-drinking normotensive rats exhibited
significant reduction of arterial plasma kinins relative to the level in
water-drinking controls. These data indicate that high salt intake,
irrespective of the level of blood pressure, causes the arterial plasma
concentration of kinins to fall.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Plasma kinin concentration in deoxycorticosterone-salt hypertension
Department of Pharmacology, University of Tennessee, Memphis.
This article has been cited by other articles:
![]() |
H. Peng, O. A. Carretero, L. Raij, F. Yang, A. Kapke, and N.-E. Rhaleb Antifibrotic Effects of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on the Heart and Kidney in Aldosterone-Salt Hypertensive Rats Hypertension, February 1, 2001; 37(2): 794 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-E. Rhaleb, X.-P. Yang, M. Nanba, E. G. Shesely, and O. A. Carretero Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats Hypertension, January 1, 2001; 37(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |